Results 31 to 40 of about 8,147 (216)
OBJECTIVE: To assess the effect of hyperthermic intraperitoneal chemotherapy (HIPEC) to eradicate intraperitoneal free cancer cells and to explore the feasibility of cytological cure for peritoneal carcinomatosis (PC).
Zhonghe Ji +5 more
doaj +1 more source
Cytoreductive HIPEC-Combined Surgery in Treatment of Advanced Ovarian Cancer
Background. Ovarian cancer ranks 5th in the structure of female oncological mortality in the Russian Federation, with a first-year post-diagnosis rate of almost 35%. In 75% cases, ovarian cancer is diagnosed at stages III—IV.
M. V. Zabelin +2 more
doaj +1 more source
HIPEC: The Complexities of Clinical Trials [PDF]
The treatment of peritoneal surface malignancies presents unique and challenging problems to the cancer clinician. These patients more than many other cancer patients often suffer from significant and disabling symptoms as a direct result of local tumor progression.
openaire +2 more sources
HIPEC for gynaecological malignancies: A last update (Review) [PDF]
Advanced-stage gynaecological cancer represents a clinical entity with challenging surgical treatment in an effort to optimize prognosis. Hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery (CRS) has been reported as a ...
Frederic Guyon +15 more
core +1 more source
HIPEC in advanced epithelial ovarian cancer: why is there controversy? [PDF]
: Purpose of review The randomized OVHIPEC study provided further evidence that adding heated intraperitoneal chemotherapy (HIPEC) to interval cytoreductive surgery significantly improved recurrence-free and overall survival in stage III epithelial ...
Brand, Alison +5 more
core +1 more source
Effect of HIPEC on thrombin generation. [PDF]
Effect of HIPEC on thrombin generation.
Abraham Marcus (5435150) +9 more
core +1 more source
HIPECology : Aspects of Postoperative Morbidity Following the HIPEC Procedure [PDF]
Peritoneal surface malignancy (PM), regardless of the dissemination site, was once considered a terminal condition. However, the introduction of a surgical approach with cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy
Dranichnikov, Paul
core
Background Comprehensive readmission morbidity studies after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are scarce. This study aimed to investigate readmissions and in-hospital morbidity after CRS and HIPEC. Methods
Paul Dranichnikov +2 more
doaj +1 more source
Peritoneal metastasis (PM) is commonly observed in patients with colorectal cancer (CRC). The outcome of these patients is poor, with an average survival of only six months without therapy, which requires a better understanding of PM biology and new ...
Mönch Dina +11 more
doaj +1 more source
Effect of HIPEC on platelet function. [PDF]
Effect of HIPEC on platelet function.
Abraham Marcus (5435150) +9 more
core +1 more source

